Hepatitis C

Survival Similar With Donor Hearts From Hepatitis C+ Donors

MONDAY, Dec. 10, 2018 -- Transplant patients with hearts from donors with hepatitis C virus (HCV) infection and obese donors have similar survival rates as patients with other donor hearts, according to two studies published in the December issue...
Related topics: Hepatitis, Virus, Virology, Obesity

Read More →

Us Spending On Physician, Clinical Services Rose 4% In 2017

An analysis from CMS shows continued slowing in the growth rate for total US healthcare spending, following a bump in 2014-2015 due to an expansion of insurance coverage and new hepatitis C drugs. Medscape Medical News
Related topics: Hepatitis

Read More →

Gilead's (gild) Harvoni And Descovy Get Approval In China

Gilead Sciences, Inc. GILD announced that the National Medical Products Administration (NMPA) has approved its hepatitis C virus (HCV) drug, Harvoni, in China.The drug has been approved for the treatment of HCV infection genotype 1-6 infection in...
Related topics: Hepatitis, Virus, Virology

Read More →

Millions Flock To Free Tests As Egypt Seeks To Eradicate Hepatitis C

When Houaida Mabrouk heard about a government campaign that offers free hepatitis C screenings, she hesitated, afraid of testing positive. But after many from her community started visiting health clinics to get checked, she changed her mind. “I...
Related topics: Hepatitis

Read More →

Targeted Hep C Testing Misses High Number Of Cases In Prisons

MONDAY, Dec. 3, 2018 -- Targeted hepatitis C virus (HCV) testing misses a substantial number of cases among individuals in correctional facilities, according to a study published online Nov. 19 in the American Journal of Preventive...
Related topics: Hepatitis, Virus, Virology, Medical Research

Read More →

Medical News Today: Hepatitis C And Hiv Coinfection

People living with HIV are at higher risk of contracting hepatitis C. This because HIV can weaken the immune system, leaving the body more vulnerable to other infections. In this article, we discuss the symptoms, prevention, and treatment for...
Related topics: Hepatitis, HIV, Virus

Read More →

Abbvie's Hcv Drug Mavyret Succeeds In Label Expansion Study

AbbVie, Inc. ABBV announced that its successful hepatitis C virus (HCV) medicine, Mavyret demonstrated high virologic cure rates in a study evaluating the 8-week, pan-genotypic, ribavirin-free, once-daily HCV treatment for an expanded patient...
Related topics: Medical Research, Hepatitis, Virus, Virology

Read More →

Medical News Today: What To Know About Hepatitis C In Men

Hepatitis C is a viral illness that affects the liver. Men tend to experience it at higher rates than women, but it is unclear why. Some people believe that it may be due to estrogen’s protective effect. Diagnosis and testing can help people find...
Related topics: Viral Hepatitis, Hepatitis, Estrogen

Read More →

Hepatitis C Treatment Works Well For Young Kids

(MedPage Today) -- Nearly all children treated with sofosbuvir/ledipasvir achieved sustained response
Related topics: Hepatitis

Read More →

Over Two Million People Living With Hep C From 2013 To 2016

TUESDAY, Nov. 6, 2018 -- During 2013 to 2016, more than two million people in the United States had current hepatitis C virus (HCV) infection, according to a study published online Nov. 6 in Hepatology. Megan G. Hofmeister, M.D., M.P.H., from the...
Related topics: Hepatitis, Virus, Virology, Medical Research

Read More →

Genetic Achilles Heel Hurts Humans Fighting Hepatitis C

An antimicrobial signaling molecule called interferon lambda 4 has lower activity against the hepatitis C virus in the vast majority of humans compared with chimpanzees and African hunter-gatherer Pygmies, according to a new study.
Related topics: Genetics, Hepatitis, Virus, Virology, Medical Research

Read More →

Many Young Drug Abusers Not Tested For Hepatitis C, Study Finds

FRIDAY, Oct. 5, 2018 -- Too few teens and young adults with an opioid addiction are tested for hepatitis C, even though they're at high risk for the liver infection, researchers say. In 2016, hepatitis C killed more than 18,000 Americans, making...
Related topics: Hepatitis, Medical Research

Read More →

Gilead (gild) To Launch Generics For Leading Hcv Treatments

Gilead Sciences, Inc. GILD announced that it plans to launch authorized generic versions of its leading hepatitis C virus (HCV) treatments — Epclusa (sofosbuvir 400mg/velpatasvir 100mg) and Harvoni (ledipasvir 90mg/sofosbuvir 400mg).The...
Related topics: Hepatitis, Virus, Virology

Read More →

This Disease Is A Top Killer And Now States Must Pay For Its Costly Treatment

Hepatitis C kills far more Americans than any other infectious disease.
Related topics: Hepatitis

Read More →

Overwhelming Evidence Shows Hepatitis C Treatment Effective For People Who Inject Drugs

Researchers are calling on an end to discriminatory health and illicit drugs policies, based on overwhelming evidence that new hepatitis C therapies are effective at curing the virus in people who inject drugs.
Related topics: Hepatitis, Medical Research, Virus, Virology

Read More →

Patrons Of 'vampire Facial' Spa May Have Been Exposed To Hiv

FRIDAY, Sept. 14, 2018 -- Customers of an Albuquerque spa who received a "vampire facial" are being warned that they may have been exposed to HIV, hepatitis B and hepatitis C through human blood used in the controversial procedure. In a vampire...
Related topics: HIV, Virus, Hepatitis, Hepatitis B

Read More →

Inovio (ino) Initiates Phase I Study On Hepatitis C Vaccine

Inovio Pharmaceuticals, Inc. INO along with Korean partner GeneOne Life Science announced that it has dosed the first patient in a phase I study, evaluating its hepatitis C vaccine GLS-6150 to boost immunity in patients. Both companies are jointly...
Related topics: Medical Research, Hepatitis, Vaccines

Read More →

Organs Infected With Hepatitis C Can Now Be Transplanted

New antiviral drugs are expanding the organs available for donation.
Related topics: Hepatitis

Read More →

Why This Gastroenterologist Decided To Treat Hepatitis C Patients

In a prior post, I shared my heretofore reluctance to prescribe medications for my hepatitis C (HCV) patients.  In summary, after consideration of the risks and benefits of the available options, I could not persuade myself — or my patients...
Related topics: Hepatitis

Read More →

Should Gilead Be Worried About This New Monthly Hiv Medication?

Gilead Sciences (NASDAQ: GILD) has seen quite a bit of competition in the hepatitis C (HCV) space, but now investors in the big biotech also need to start worrying about potential competition for its HIV drugs, a segment that has been growing.Drug...
Related topics: HIV, Virus, Nasdaq, Hepatitis

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.